Emcure Pharmaceutical’s Rs.5,000 crore IPO has got SEBI approval and will open in first week of February. Fresh issue will be Rs.1,100 crore and Rs.3,900 crore by OFS. Emcure will utilize Rs.947 crore to pre-pay loans. It is a market leader in HIV anti-viral, gynaecology and blood-related therapeutic areas.
Emcure Pharmaceutical’s Rs.5,000 crore IPO has got SEBI approval and will open in first week of February. Fresh issue will be Rs.1,100 crore and Rs.3,900 crore by OFS. Emcure will utilize Rs.947 crore to pre-pay loans. It is a market leader in HIV anti-viral, gynaecology and blood-related therapeutic areas.